Related Experiment Video
Updated: Mar 25, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Personalizing Medicine in Head and Neck Squamous Cell Carcinoma: The Rationale for Combination Therapies
Andrew C Birkeland1, J Chad Brenner2
1Department of Otolaryngology - Head and Neck Surgery, The University of Michigan Medical School, Ann Arbor, MI.
Abstract:
Personalized medicine, in which individual tumor genetics drive the selection of targeted therapies and treatment plans for each patient, has recently emerged as the next generation of cancer therapy. Unfortunately, personalized medicine trials have had limited success in tumors that have complex combinations of disruptive genomic events, which drive differential responses to targeted therapies. Here, we will use head and neck squamous cell carcinoma as a model for genetically complex disease and discuss novel approaches to enhance personalized medicine trials for these complicated cases.
Insights
Personalized medicine uses tumor genetics for cancer treatment. Novel approaches are needed to improve its success in genetically complex cancers like head and neck squamous cell carcinoma.
Area of Science:
- Oncology
- Genomics
- Translational Medicine
Background:
- Personalized medicine, guided by individual tumor genetics, represents a new frontier in cancer therapy.
- However, its application is limited in genetically complex tumors with multiple genomic alterations.
- These complex genomic events lead to varied responses to targeted therapies.
Purpose of the Study:
- To address the limited success of personalized medicine in genetically complex cancers.
- To utilize head and neck squamous cell carcinoma as a model for studying these complex cases.
- To explore and propose novel strategies for enhancing personalized medicine trials.
Main Methods:
- Utilizing head and neck squamous cell carcinoma as a model system.
- Analyzing complex genomic events within tumors.
- Developing and discussing novel approaches for trial enhancement.
Main Results:
- Genetically complex tumors present significant challenges to personalized medicine.
- Differential responses to targeted therapies are driven by combinations of genomic events.
- Head and neck squamous cell carcinoma serves as a relevant model for such complexity.
Conclusions:
- Novel approaches are required to improve the efficacy of personalized medicine.
- Enhancing personalized medicine trials is crucial for treating genetically complex cancers.
- Future strategies should focus on overcoming genomic complexity in cancer treatment.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Targeted Cancer Therapies
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

